Literature DB >> 11896322

Potential role for rFVIIa in transfusion medicine.

Ulla Hedner1, Elisabeth Erhardtsen.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11896322     DOI: 10.1046/j.1537-2995.2002.00017.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  19 in total

1.  Fish as bioreactors: transgene expression of human coagulation factor VII in fish embryos.

Authors:  Gyulin Hwang; Ferenc Müller; M Aziz Rahman; Darren W Williams; Paul J Murdock; K John Pasi; Geoffrey Goldspink; Hamid Farahmand; Norman Maclean
Journal:  Mar Biotechnol (NY)       Date:  2004-04-29       Impact factor: 3.619

2.  Aortic valve replacement in a Jehovah's Witness: a case of multi-disciplinary clinical management for bloodless surgery.

Authors:  John Jungpa Park; Christopher C Lang; Lynn Manson; Edward T Brackenbury
Journal:  BMJ Case Rep       Date:  2012-02-21

3.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

Review 4.  Recombinant factor VIIa: a review on its clinical use.

Authors:  Massimo Franchini
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

Review 5.  The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

6.  7 Procoagulators.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

7.  Implementation of an off-label recombinant factor VIIa protocol for patients with critical bleeding at an academic medical center.

Authors:  Jonathan Bain; Daniel Lewis; Andrew Bernard; Kevin Hatton; Hassan Reda; Jeremy Flynn
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

Review 8.  Recombinant factor VIIa as haemostatic therapy in advanced liver disease.

Authors:  Pier Mannuccio Mannucci; Massimo Franchini
Journal:  Blood Transfus       Date:  2012-10-10       Impact factor: 3.443

9.  Comparison of Neonatal and Adult Fibrin Clot Properties between Porcine and Human Plasma.

Authors:  Kimberly A Nellenbach; Seema Nandi; Alexander Kyu; Supriya Sivadanam; Nina A Guzzetta; Ashley C Brown
Journal:  Anesthesiology       Date:  2020-05       Impact factor: 7.892

10.  The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII.

Authors:  Amanda Zatta; Zoe Mcquilten; Rangi Kandane-Rathnayake; James Isbister; Scott Dunkley; John Mcneil; Peter Cameron; Louise Phillips
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.